MedPath

Streptomycin

Generic Name
Streptomycin
Drug Type
Small Molecule
Chemical Formula
C21H39N7O12
CAS Number
57-92-1
Unique Ingredient Identifier
Y45QSO73OB

Overview

Streptomycin, an antibiotic derived from Streptomyces griseus, was the first aminoglycoside to be discovered and used in practice in the 1940s. Selman Waksman and eventually Albert Schatz were recognized with the Nobel Prize in Medicine for their discovery of streptomycin and its antibacterial activity. Although streptomycin was the first antibiotic determined to be effective against mycobacterium tuberculosis, it has fallen out of favor due to resistance and is now primarily used as adjunctive treatment in cases of multi-drug resistant tuberculosis.

Background

Streptomycin, an antibiotic derived from Streptomyces griseus, was the first aminoglycoside to be discovered and used in practice in the 1940s. Selman Waksman and eventually Albert Schatz were recognized with the Nobel Prize in Medicine for their discovery of streptomycin and its antibacterial activity. Although streptomycin was the first antibiotic determined to be effective against mycobacterium tuberculosis, it has fallen out of favor due to resistance and is now primarily used as adjunctive treatment in cases of multi-drug resistant tuberculosis.

Indication

Although streptomycin was the first antibiotic available for the treatment of mycobacterium tuberculosis, it is now largely a second line option due to resistance and toxicity. Streptomycin may also be used to treat a variety of other infections caused by susceptible strains of aerobic bacteria where other less toxic agents are ineffective. Examples include: Yersinia pestis, Francisella tularensis, Brucella, Calymmatobacterium granulomatis (donovanosis, granuloma inguinale), H. ducreyi (chancroid), H. influenzae (in respiratory, endocardial, and meningeal infections - concomitantly with another antibacterial agents). K. pneumoniae pneumonia (concomitantly with another antibacterial agent), E.coli, Proteus, A.aerogenes, K. pneumoniae, and Enterococcus faecalis in urinary tract infections, Streptococcus viridans, Enterococcus faecalis (in endocardial infections - concomitantly with penicillin), and Gram-negative bacillary bacteremia (concomitantly with another antibacterial agent).

Associated Conditions

  • Bacteremia
  • Bacterial Infections caused by susceptible bacteria
  • Chancroid
  • Disseminated mycobacterium avium complex infection
  • Flu caused by Influenza
  • Granuloma Inguinale
  • Menière's Disease
  • Mycobacterium Avium Intracellulare Complex (MAC)
  • Mycobacterium kansasii infection
  • Mycobacterium marinum infection
  • Plague
  • Pneumonia
  • Tuberculosis (TB)
  • Tularemia
  • Urinary Tract Infection

FDA Approved Products

Streptomycin
Manufacturer:XGen Pharmaceuticals DJB, Inc.
Route:INTRAMUSCULAR
Strength:1 g in 1 1
Approved: 2023/08/15
NDC:39822-0706

Singapore Approved Products

STREPTOMYCIN SULFATE FOR INJECTION 1 g/vial
Manufacturer:PT. MEIJI INDONESIAN PHARMACEUTICAL INDUSTRIES
Form:INJECTION, POWDER, FOR SOLUTION
Strength:1 g/vial
Online:Yes
Approved: 1988/05/19
Approval:SIN01388P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath